‘Foreign freeloading nations': Trump takes aim at drug companies in latest threat to PBS
Trump issued letters to the bosses of 17 drug firms on Thursday (Friday AEST) demanding they extend 'most favoured nation' pricing to the US Medicaid scheme, and guarantee that pricing level for new drugs. It means other comparable, high-income nations could not be offered cheaper prices than the US.
'Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations,' Trump wrote in the letters.
'US trade policy will endeavour to support this. However, increased revenues abroad must be repatriated to lower drug prices for American patients and taxpayers through an explicit agreement with the United States.'
The letters were sent to major drugmakers including Pfizer, Eli Lilly, AstraZeneca and Johnson & Johnson, and published on Trump's social media.
Loading
They did not mention Australia but referred to putting 'an end to the free ride of American innovation by European and other developed nations'.
Under the PBS, Australians can buy life-saving drugs worth thousands of dollars for as little as $31.60 a script after the government negotiates with the drug company to secure a lower price based on buying in bulk.
Trump's letter makes explicit instructions to drug firms to 'negotiate harder' and return those extra profits to American patients and taxpayers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AU Financial Review
13 minutes ago
- AU Financial Review
Trump's Fed pick puts the Aussie dollar in the spotlight
The Australian dollar could be one of the biggest beneficiaries from US President Donald Trump's continued attack on the independence of the Federal Reserve that has already unnerved financial markets and significantly weakened the greenback. Bank of America said of the world's 10 most traded currencies, buying the Aussie was the best way to trade the weakening US dollar, which it said could climb to as much as US69¢ from US64.61¢, currently.
7NEWS
13 minutes ago
- 7NEWS
Nicotine poisonings soar in babies and toddlers
The number of young children falling ill after getting their little hands on nicotine products such as pouches and vape e-liquids has skyrocketed in recent years in the US. From 2010 to 2023, US poison centres reported 134,663 cases of nicotine poisonings among kids younger than age 6, according to a study published in Pediatrics, a journal of the American Academy of Pediatrics. Nearly all occurred at home. The cases included exposures to nicotine pouches, chewing tobacco, regular cigarettes, vapes and nicotine replacement products such as gum and lozenges. But it is nicotine pouches, like the wildly popular Zyn, that are behind the most significant rise in accidental nicotine poisonings among young kids. The new research found the rate of poisonings involving nicotine pouches among kids younger than 6 rose from 0.48 per 100,000 children in 2020 to 4.14 per 100,000 in 2023. That is an increase of 763 per cent in just three years — a startling finding that correlates with a surge in sales of nicotine pouches. Nicotine pouches — which users tuck between their lip and gum and later discard — can contain as much as 6mg of nicotine, a stimulant, and have been promoted as tobacco-free, spit-free and hands-free alternatives to cigarettes and chewing tobacco. They are not, however, approved by the Food and Drug Administration as nicotine replacement products used to help quit smoking. Philip Morris, which owns Zyn, said: 'Zyn's packaging is designed to be child-resistant.' A 2021 study from the Centres for Disease Control and Prevention's Office on Smoking and Health (one of several public health groups dismantled under the Trump administration) found that sales of nicotine pouches rose dramatically in the past decade, from $709,000 in 2016 to $216 million by mid-2020. 'It was just a matter of time before they fell into the hands of younger kids,' American Academy of Paediatrics spokesperson Dr Molly O'Shea said. 'It's unfortunate but not shocking.' Why is nicotine toxic to little kids? Nicotine is a chemical that is highly toxic and could easily exceed a fatal dose in small children, according to a 2013 study. The chemical increases heart rate and blood pressure and could lead to nausea, vomiting or even coma, the study authors wrote. Most cases included in the new research were not serious enough to warrant medical attention. But 39 children had significant side effects, such as trouble breathing and seizures, Central Ohio Poison Centre and study co-author Natalie Rine said. Most nicotine poisoning cases, 76 per cent, were babies and toddlers younger than age 2. Two children, a one-year-old boy and an 18-month-old boy, died after ingesting liquid nicotine used in vapes. 'It's good that the majority of kids in the study actually did pretty well,' Rine said. 'Most kids had either minor symptoms or no symptoms and didn't require any medical management. 'But two deaths is a lot, especially for something considered a preventable death.' The study 'adds to concerns about the health risks that nicotine pouches pose to kids,' Campaign for Tobacco-Free Kids president Yolonda Richardson, said. She was not involved in the new research. 'It's critical that we educate parents, childcare providers and healthcare providers about the health risks of these products, including poisoning.' How to reduce nicotine poisonings in kids Kids are curious by nature. Babies and toddlers in particular explore their worlds by putting things in their mouth. And they're masters at breaking into drawers and cabinets to find new 'toys'. Many canisters of nicotine pouches are not equipped with child-resistant packaging. They taste good, too. Mint and fruit flavours are almost always added. O'Shea said it's critical that all nicotine products are placed far out of reach of children. 'That doesn't mean in your purse, in your back pocket or on the counter,' she said. 'It means locked away.' It's not just parents and other adult caregivers who must be mindful of their nicotine products. An April study from the Keck School of Medicine of the University of Southern California found the use of nicotine pouches among high school students nearly doubled between 2023 and 2024. 'It's easy for a teenager to be using this product and have parents be unaware,' O'Shea said. 'It's important for parents to be talking with their teenagers about products like this and having open dialogue in a non-judgmental way in order to ascertain any risk.'
West Australian
44 minutes ago
- West Australian
Caterpillar sees US tariff hit of up to $US15b this year
Caterpillar has given investors annual guidance for the first time on how much tariffs will impact the maker of iconic yellow diggers and bulldozers this year, as the Trump administration's trade war deepens. The heavy-equipment maker said Tuesday after reporting earnings that it expects to face net incremental tariffs of $US1.3 billion to $US1.5 billion ($23.1b) this year — including as much as $US500 million in its third quarter — though its new CEO said the company will be able to offset the impact. Caterpillar's outlook is important because it is one of the world's biggest makers of machinery for mining and construction. The US manufacturer's second-quarter results already reflect the effect of tariffs, with costs coming in at the top end of its estimated range disclosed in April. 'We're going to mitigate the impact of tariffs,' chief executive Joe Creed, who succeeded Jim Umpleby in May, said on an earnings call. 'Exactly which levers we're going to pull, we're looking for a little more clarity before we reach into those.' Shares of Caterpillar, which had proved resilient this year with a 20 per cent gain, fell 1.2 per cent as of 10.44am in New York. Caterpillar said it now expects full-year adjusted operating profit to fall in the bottom of its annual target range, even with higher annual sales. Baird analysts calculated that tariffs will equate to a 300 basis point drag on margins, up from its previous expectation of 200 basis points, according to a note to clients after the earnings release. The tariff outlook came after Caterpillar posted adjusted earnings of $US4.72 a share in the second quarter, falling short of the $US4.88 median estimate of analysts polled by Bloomberg. The Irving, Texas-based company said total sales slipped in both construction and resource industries in the quarter, while its energy and transportation unit had higher sales. Operating profit for its machinery, energy and transportation segments fell 24 per cent from the year-earlier period mainly due to unfavorable manufacturing costs largely reflecting the impact of the higher duties. Bloomberg
